Prothena Corp. plc Stock
Prothena Corp. plc Stock
Prothena Corp. plc gained 1.940% today.
Prothena Corp. plc is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
Based on the current price of 21.6 € the target price of 80 € shows a potential of 270.37% for Prothena Corp. plc which would more than double the current price.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Prothena Corp. plc | 1.940% | 5.882% | 8.543% | -68.467% | -37.931% | 9.091% | - |
Ardelyx Inc. | 0.340% | -0.416% | 17.913% | 119.146% | 24.360% | 27.221% | - |
Evolus Inc | 5.130% | 4.237% | 16.038% | 36.667% | 35.912% | 72.028% | - |
Salarius Pharmaceuticals Inc. | 7.850% | -5.069% | -1.905% | -64.174% | -25.766% | -98.542% | -99.992% |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat